Wells Fargo raised the price target for the Oscar Health Inc. (NYSE:OSCR) stock to “an Overweight”. The rating was released on March 30, 2021. The research report from Goldman has initiated the stock to Buy, with a price target set at $44. The stock was initiated by Credit Suisse, who disclosed in a research note on March 29, 2021, to Outperform and set the price objective to $34. In their research brief published March 29, 2021, Cowen analysts initiated the Oscar Health Inc. stock to Market Perform with a price target of $29.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
The latest trade, Performances and Moving Averages give us the following Picture
The share price of Oscar Health Inc. (NYSE:OSCR) dipped -4.54% to close Tuesday’s market session at $12.40, lower as compared to yesterday’s close. The stock price fluctuated between $12.32 and $13.16 throughout the trading session with the volume trading being 3478381 shares, which represented a significant variation when compared to the three months average volume of 734.35K shares. The firm’s stock price fluctuated -5.05% within the last five trades and -33.94% within the last 30 trades, which was a significant change from the beginning of this year. OSCR stock is trading at a margin of -17.52%, -34.14% and -46.47% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
As of the close of trading, OSCR deals in the Healthcare domain. The stock is trading -66.49 percent below its 52-week high and 2.82 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is null. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does Oscar Health Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?
The stock’s market cap achieved a total value of $2.45 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 3.60 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 1.48, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 0.30 percent of Oscar Health Inc. shares are owned by insiders, and 90.10 percent are held by financial institutions. Kushner Joshua, the Co-Founder and Vice Chairman at Oscar Health Inc. (OSCR) has bought 1,074,342 shares of firm on Aug 24 at a price of $12.69 against the total amount of $13.63 million. In another inside trade, Thrive Partners VII Growth GP,, 10% Owner of Oscar Health Inc. (NYSE:OSCR) bought 1,074,342 shares of the firm on Aug 24 for a total worth of $13.63 million at a price of $12.69. An inside trade which took place on Aug 23, Co-Founder and Vice Chairman of Oscar Health Inc. Kushner Joshua bought 125,900 shares of firm against total price of $1.64 million at the cost of $13.01 per share.